Cargando…
Obesity hormone leptin: a new target in breast cancer?
Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved in the regulation of food intake and energy balance. In addition, leptin can stimulate mitogenic and angiogenic processes in peripheral organs. Because leptin levels are elevated in obese individuals and excess bo...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851379/ https://www.ncbi.nlm.nih.gov/pubmed/17274833 http://dx.doi.org/10.1186/bcr1638 |
_version_ | 1782132962057256960 |
---|---|
author | Surmacz, Eva |
author_facet | Surmacz, Eva |
author_sort | Surmacz, Eva |
collection | PubMed |
description | Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved in the regulation of food intake and energy balance. In addition, leptin can stimulate mitogenic and angiogenic processes in peripheral organs. Because leptin levels are elevated in obese individuals and excess body weight has been shown to increase breast cancer risk in postmenopausal women, attempts have been made to evaluate whether leptin can promote breast cancer. Data obtained in cell and animal models and analyses of human breast cancer biopsies indeed suggest such an involvement. Furthermore, a recent report clearly shows that targeting leptin signaling may reduce mammary carcinogenesis. Thus, leptin should become a new attractive target in breast cancer. |
format | Text |
id | pubmed-1851379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18513792007-04-12 Obesity hormone leptin: a new target in breast cancer? Surmacz, Eva Breast Cancer Res Viewpoint Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved in the regulation of food intake and energy balance. In addition, leptin can stimulate mitogenic and angiogenic processes in peripheral organs. Because leptin levels are elevated in obese individuals and excess body weight has been shown to increase breast cancer risk in postmenopausal women, attempts have been made to evaluate whether leptin can promote breast cancer. Data obtained in cell and animal models and analyses of human breast cancer biopsies indeed suggest such an involvement. Furthermore, a recent report clearly shows that targeting leptin signaling may reduce mammary carcinogenesis. Thus, leptin should become a new attractive target in breast cancer. BioMed Central 2007 2007-01-26 /pmc/articles/PMC1851379/ /pubmed/17274833 http://dx.doi.org/10.1186/bcr1638 Text en Copyright © 2007 BioMed Central Ltd |
spellingShingle | Viewpoint Surmacz, Eva Obesity hormone leptin: a new target in breast cancer? |
title | Obesity hormone leptin: a new target in breast cancer? |
title_full | Obesity hormone leptin: a new target in breast cancer? |
title_fullStr | Obesity hormone leptin: a new target in breast cancer? |
title_full_unstemmed | Obesity hormone leptin: a new target in breast cancer? |
title_short | Obesity hormone leptin: a new target in breast cancer? |
title_sort | obesity hormone leptin: a new target in breast cancer? |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851379/ https://www.ncbi.nlm.nih.gov/pubmed/17274833 http://dx.doi.org/10.1186/bcr1638 |
work_keys_str_mv | AT surmaczeva obesityhormoneleptinanewtargetinbreastcancer |